Elise S. Eerenberg
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
Journal: Thrombosis and haemostasis
Published: August 29, 2018
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
Journal: Thrombosis and haemostasis
Published: January 06, 2018
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
Journal: Thrombosis and haemostasis
Published: December 19, 2016
The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
Journal: Cardiovascular research
Published: December 11, 2015
Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model.
Journal: JACC. Cardiovascular interventions
Published: September 15, 2015
Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 25, 2014
The potential therapeutic benefit of targeting ADAMTS13 activity.
Journal: Seminars in thrombosis and hemostasis
Published: December 17, 2013
Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
Journal: European heart journal
Published: April 19, 2013
Contra: "Antidotes for novel anticoagulants?"--Do we really need them.
Journal: Thrombosis and haemostasis
Published: May 10, 2012
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Journal: Circulation
Published: September 09, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026